Terms: = Breast cancer AND STAT6, D12S1644, 6778, ENSG00000166888, IL-4-STAT, P42226, STAT6B, STAT6C AND Treatment
21 results:
1. Anti-metastatic effects of AGS-30 on breast cancer through the inhibition of M2-like macrophage polarization.
Li J; Liu Z; Wu X; Lee SM; Seto SW; Zhang J; Zhou GC; Leung GP
Biomed Pharmacother; 2024 Mar; 172():116269. PubMed ID: 38367549
[TBL] [Abstract] [Full Text] [Related]
2. Sarcoma care in the era of precision medicine.
Wallander K; Öfverholm I; Boye K; Tsagkozis P; Papakonstantinou A; Lin Y; Haglund de Flon F
J Intern Med; 2023 Dec; 294(6):690-707. PubMed ID: 37643281
[TBL] [Abstract] [Full Text] [Related]
3. Garcinone E suppresses breast cancer growth and metastasis by modulating tumor-associated macrophages polarization via stat6 signaling.
Nie X; Fu L; Cheng Y; Wu X; Lv K; Li R; Wu Y; Leung GP; Fu C; Lee SM; Seto SW; Zhang J; Li J
Phytother Res; 2023 Oct; 37(10):4442-4456. PubMed ID: 37259475
[TBL] [Abstract] [Full Text] [Related]
4. Immunomodulatory Role of Diospyros peregrina Fruit Preparation in breast cancer by Utilizing Macrophage Mediated Antigen Presentation and T Helper Cell (Th) Differentiation.
Mahalakshmi Surendran A; Rai A; Rakshit S; George M; Sarkar K
Clin Breast Cancer; 2023 Apr; 23(3):e95-e102. PubMed ID: 36641322
[TBL] [Abstract] [Full Text] [Related]
5. CD30 Regulation of IL-13-stat6 Pathway in breast Implant-Associated Anaplastic Large Cell Lymphoma.
Kadin ME; Morgan J; Wei W; Song Z; Yang Y
Aesthet Surg J; 2023 Feb; 43(2):137-146. PubMed ID: 35999655
[TBL] [Abstract] [Full Text] [Related]
6. STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges.
Wong GL; Manore SG; Doheny DL; Lo HW
Semin Cancer Biol; 2022 Nov; 86(Pt 3):84-106. PubMed ID: 35995341
[TBL] [Abstract] [Full Text] [Related]
7. LncRNA-SNHG1 promotes macrophage M2-like polarization and contributes to breast cancer growth and metastasis.
Zong S; Dai W; Guo X; Wang K
Aging (Albany NY); 2021 Oct; 13(19):23169-23181. PubMed ID: 34618681
[TBL] [Abstract] [Full Text] [Related]
8. Hedgehog Signaling Regulates Metabolism and Polarization of Mammary Tumor-Associated Macrophages.
Hinshaw DC; Hanna A; Lama-Sherpa T; Metge B; Kammerud SC; Benavides GA; Kumar A; Alsheikh HA; Mota M; Chen D; Ballinger SW; Rathmell JC; Ponnazhagan S; Darley-Usmar V; Samant RS; Shevde LA
Cancer Res; 2021 Nov; 81(21):5425-5437. PubMed ID: 34289986
[TBL] [Abstract] [Full Text] [Related]
9. Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action.
Xue Y; Gao S; Gou J; Yin T; He H; Wang Y; Zhang Y; Tang X; Wu R
Expert Opin Drug Deliv; 2021 Feb; 18(2):187-203. PubMed ID: 32954856
[TBL] [Abstract] [Full Text] [Related]
10. Microarray data analysis reveals gene expression changes in response to ionizing radiation in MCF7 human breast cancer cells.
Bai J; Luo Y; Zhang S
Hereditas; 2020 Sep; 157(1):37. PubMed ID: 32883354
[TBL] [Abstract] [Full Text] [Related]
11. Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting STAT5 and stat6.
Jiang L; Zhao XH; Mao YL; Wang JF; Zheng HJ; You QS
J Exp Clin Cancer Res; 2019 Nov; 38(1):465. PubMed ID: 31718693
[TBL] [Abstract] [Full Text] [Related]
12. stat6 knockdown using multiple siRNA sequences inhibits proliferation and induces apoptosis of human colorectal and breast cancer cell lines.
Salguero-Aranda C; Sancho-Mensat D; Canals-Lorente B; Sultan S; Reginald A; Chapman L
PLoS One; 2019; 14(5):e0207558. PubMed ID: 31075146
[TBL] [Abstract] [Full Text] [Related]
13. Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of stat6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory breast cancer.
Rahal OM; Wolfe AR; Mandal PK; Larson R; Tin S; Jimenez C; Zhang D; Horton J; Reuben JM; McMurray JS; Woodward WA
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):1034-1043. PubMed ID: 29485045
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of IL-6/STAT3 signaling in human cancer cells using Evista.
Shi W; Yan D; Zhao C; Xiao M; Wang Y; Ma H; Liu T; Qin H; Zhang C; Li C; Lin J; Li S; Lv J; Lin L
Biochem Biophys Res Commun; 2017 Sep; 491(1):159-165. PubMed ID: 28711499
[TBL] [Abstract] [Full Text] [Related]
15. Dihydroorotate dehydrogenase (DHODH) inhibitors affect ATP depletion, endogenous ROS and mediate S-phase arrest in breast cancer cells.
Mohamad Fairus AK; Choudhary B; Hosahalli S; Kavitha N; Shatrah O
Biochimie; 2017 Apr; 135():154-163. PubMed ID: 28196676
[TBL] [Abstract] [Full Text] [Related]
16. IL-4, a direct target of miR-340/429, is involved in radiation-induced aggressive tumor behavior in human carcinoma cells.
Kim ES; Choi YE; Hwang SJ; Han YH; Park MJ; Bae IH
Oncotarget; 2016 Dec; 7(52):86836-86856. PubMed ID: 27895317
[TBL] [Abstract] [Full Text] [Related]
17. Targeting IL13Ralpha2 activates stat6-TP63 pathway to suppress breast cancer lung metastasis.
Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
[TBL] [Abstract] [Full Text] [Related]
18. Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs.
Jia X; Yu F; Wang J; Iwanowycz S; Saaoud F; Wang Y; Hu J; Wang Q; Fan D
Breast Cancer Res Treat; 2014 Nov; 148(2):291-302. PubMed ID: 25311112
[TBL] [Abstract] [Full Text] [Related]
19. Integrity of the LXXLL motif in stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.
Wei M; He Q; Yang Z; Wang Z; Zhang Q; Liu B; Gu Q; Su L; Yu Y; Zhu Z; Zhang G
BMC Cancer; 2014 Jan; 14():10. PubMed ID: 24401087
[TBL] [Abstract] [Full Text] [Related]
20. BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib.
Godinho MF; Wulfkuhle JD; Look MP; Sieuwerts AM; Sleijfer S; Foekens JA; Petricoin EF; Dorssers LC; van Agthoven T
Br J Cancer; 2012 Sep; 107(6):947-55. PubMed ID: 22892392
[TBL] [Abstract] [Full Text] [Related]
[Next]